Prednisone is not the only steroid commonly used for migraine relief. Methylprednisolone sodium succinate (Solu-Medrol) can be given intravenously in an in-patient or emergency room setting.

Prednisone may also cause osteoporosis, especially with long-term use. This condition can occur in anyone, but it’s more common in females than males.

The Prednisone Problem Patients with severe asthma are most often referred to consultants for their persistent oral corticosteroids requirements, recurrent exacerbations and debilitating symptoms.

Even though international guidelines recommend prednisone to be used as standard-of-care for pulmonary sarcoidosis, these recommendations have not been based on randomized clinical trials.

The aims of this study are (a) to test if 12.5 mg prednisone daily is an adequate starting dose in PMR and (b) to evaluate the factors that could predict a positive response to this initial dose.